Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Lowered to $9.50 at Canaccord Genuity Group

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective reduced by Canaccord Genuity Group from $10.00 to $9.50 in a research report report published on Wednesday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock.

Several other equities research analysts have also recently weighed in on the company. Lake Street Capital lowered their target price on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, September 11th. Oppenheimer lowered their price objective on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating for the company in a research note on Monday, October 21st. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a report on Friday, July 19th. Finally, Roth Mkm dropped their price objective on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th. Four analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $12.13.

Bioceres Crop Solutions Trading Down 3.9 %

NASDAQ BIOX opened at $6.17 on Wednesday. The stock has a market cap of $387.78 million, a PE ratio of 308.65 and a beta of 0.49. Bioceres Crop Solutions has a 12 month low of $5.71 and a 12 month high of $14.05. The company’s 50-day moving average price is $7.50 and its 200-day moving average price is $9.75. The company has a current ratio of 1.27, a quick ratio of 0.86 and a debt-to-equity ratio of 0.37.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its earnings results on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The company had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. During the same quarter in the prior year, the company earned ($0.07) earnings per share. Equities research analysts forecast that Bioceres Crop Solutions will post 0.33 earnings per share for the current year.

Hedge Funds Weigh In On Bioceres Crop Solutions

Large investors have recently added to or reduced their stakes in the company. Sumitomo Mitsui Trust Holdings Inc. bought a new position in shares of Bioceres Crop Solutions during the 2nd quarter worth approximately $472,000. Fourth Sail Capital LP increased its position in shares of Bioceres Crop Solutions by 20.5% during the second quarter. Fourth Sail Capital LP now owns 1,961,825 shares of the company’s stock worth $21,992,000 after purchasing an additional 334,195 shares in the last quarter. Oppenheimer & Co. Inc. purchased a new stake in shares of Bioceres Crop Solutions during the 1st quarter valued at $139,000. Ping Capital Management Inc. acquired a new stake in shares of Bioceres Crop Solutions in the 2nd quarter worth $448,000. Finally, Lazard Asset Management LLC purchased a new position in Bioceres Crop Solutions during the 1st quarter worth $212,000. 17.68% of the stock is currently owned by institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.